Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-07-25
1997-04-01
Walsh, Stephen G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
424 7804, 424 7806, A61K 3810
Patent
active
056165625
ABSTRACT:
Healing of wounds in mammalian tissue may be enhanced by the application of certain neuropeptides, optionally in combination with known growth promoting hormones. Exemplary neuropeptides include tachykinins, such as substance P, substance K, and the like, as well as calcitonin gene-related peptides. The compositions include a carrier or vehicle suitable for topical application and are utilized by applying to the site of the wound. Wounds resulting from trauma, surgery, and disease may be treated. The compositions promote elaboration of cellular matrices and development of cellular attachment mechanisms in addition to stimulating cellular proliferation.
REFERENCES:
patent: 3862114 (1975-01-01), Scandrett
patent: 4059693 (1977-11-01), Stewart
patent: 4549986 (1985-10-01), Evans et al.
patent: 4861757 (1989-08-01), Antoniades et al.
patent: 4889919 (1989-12-01), Murray et al.
patent: 5070075 (1991-12-01), Rotwein et al.
patent: 5093317 (1992-03-01), Lewis et al.
Stjernschantz et al, "Role of Substance P in . . . Eye" Naunyn-Schmid. Arch. Pharmacol. 321:329-335 (1982).
Tomlinson, et al., "Deficient Axonal Transport of Substance P in Streptozocin-Induced Diabetic Rats" (1988), Diabetes, 37:488-493.
Gorio, et al., "Peptide Alterations in Autonomic Diabetic Neuropathy Prevented by Acetyl-L-Carnitine" (1992), Int. J. Clin. Pharm. Res., 12:(5-6):225-230.
Robinson, et al., "Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor `Statil`" (1987), Statil. Brain Res., 426:339-348.
Fowler, "Wound Healing in the Corneal Epithelium in Diabetic and Normal Rats" (1980), Exp. Eye Res., 31:167-179 .
Yee, et al., "Corneal endothelial changes in diabetic dogs" (1985), Eye Res., 4:759-766.
Wyman, et al., "The dog as a model for ocular manifestations of high concentrations of blood sugars" (1988), JAVMA, 193(9):1153-1156.
Jones, et al., "Calcitonin Gene-Related Peptide and Corneal Innervation: A Developmental Study in the Rat" (1991), J. Comp. Neurol., 313:132-150.
Di Giulio, et al., "Acetyl-L-Carnitine Prevents Substance P Loss in the Sciatic Nerve and Lumbar Spinal Cord of Diabetic Animals" (1992), Int. J. Clin. Pharm. Res., 12(5/6):243-246.
Datiles, et al., "Corneal Re-epithelialization in Galactosemic Rats" (1983), Invest. Ophthalmol. Vis. Sci., 24:563-569.
Foulks, et al., "Factors Related to Corneal Epithelial Complications After Closed Vitrectomy in Diabetics" (1979), Arch. Ophthalmol., 97:1076-1078.
Schultz, et al., "Diabetic Keratopathy" (1981), Tr. Am. Ophth. Soc., 79:180-199.
Crosson, et al., "Epithelial Wound Closure in the Rabbit Cornea" (1986), Invest. Ophthalmol. Vis. Sci., 27:464-473.
Engerman et al., "Epithelial and Mesothelial Basement Membranes in Diabetic Patients and Dogs" (1982), Diabetologia, 23:521-524.
Tullo, et al., "Corneal Sensitivity and Substance P in Experimental Herpes Simplex Keratitis in Mice" (1983), Invest. Ophthalmol. Vis. Sci., 24:596-598.
Fukushi, et al., "Reepithelialization of Denuded Corneas in Diabetic Rats" (1980), Exp. Eye Res., 31:611-621.
Willars, et al., "Substance P levels in peripheral nerve, skin, atrial myocardium and gastrointestinal tract of rats with long-term diabetes mellitus" (1989), J. Neurol. Sci., 91:153-164.
Keoleian, et al., "Structural and Functional Studies of the Corneal Endothelium in Diabetes Mellitus" (1992), Am. J. Ophthalmol., 113:64-70.
Ziche, et al., "NK.sub.1 -receptors mediate the proliferative response of human fibroblasts to tachykinins" (1990), Br. J. Pharm., 100:11-14.
Stjernschantz et al, Invest. Ophthalmol. Vis. Sci. 20(1):53-60 (1981).
Li et al, PNAS 77:4379-4381 (Jul. 1980).
Spevak et al, Byull, Eksp. Biol. Med. 107(6):739-743 (1989) abstracted in Biol. Abst. 89(1):AB-134 Ref No. 1327 (Jan. 1990).
A.K.C. Li et al., Proc. Natl. Acad. Sci. USA 77:4379-4381, Jul. 1980.
Zachary et al. (1987) Develop. Biol. 124:295.
Sakiyama et al. (1984) Develop. Brain Res. 13:275.
Shimizu et al. (1984) Naunyn-Schmiedeberg Arch. Phar. 326:347.
Gamse et al. (1981) Naunyn-Schmiedeberg Arch. Phar. 317:140.
Tervo (1981) Acta Ophthal. 59;737.
Lembeck et al. (1981) Naunyn-Schmiedeberg Arch. Phar. 316:240.
Nilsson et al. (1985) Nature 315:61.
Nilsson et al. (1986) Biochem. Biophys. Res. Comm. 137:167.
Payan (1985) Biochem. Biophys. Res. Comm. 130:104.
Payan et al. (1983) J. Immunol. 131:1613.
Payan et al. (1984) J. Immunol. 133:3260.
Lotz et al. (1987) Science 235:893.
Gamse et al. (1986) Neuroscience Letters 64:287.
Tanaka et al. (1985) J. Cell. Physiol. 123:191.
Quirion and Dam in: Substance P Metabolism and Biological Actions, Jordan and Oehme, eds., Taylor & Francis, London, 1985, Chapter 4, "Multiple Tackykinin Receptors", p. 46.
Mannis Mark J.
Murphy Christopher J.
Reid Ted W.
LandOfFree
Methods and compositions using substance P to promote wound heal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions using substance P to promote wound heal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions using substance P to promote wound heal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-538923